CAS: 105580-45-8; 4-(2,3-Dichlorophenyl)-5-(Methoxycarbonyl)-2,6-Dimethyl-1,4-Dihydropyridine-3-Carboxylic Acid

结构式图片

上下游产品

CAS号138279-25-1 3-methyl 5-((pi... | CAS号138299-11-3 bis(pivaloyloxy...

合成工艺路线路线简述

    海关参考信息

    • 2905130000-正丁醇
      2905290000-其他不饱和一元醇
      2905399099-其他二元醇
      2905499000-其他多元醇
      2905590090-其他无环醇的卤化、磺化等衍生物
    • 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
    • 详情请参考:📖 海关编码查询和海关进出口税则

    专利信息


    专利号:WO-2011130852-A1
    优先权日:2010-04-21
    标题:Preparation of intermediates for the synthesis of dihydropyridine calcium channel blockers
    发明人:SOUZA FABIO; PAN MING
    权利人:ALPHORA RES INC; SOUZA FABIO; PAN MING
    摘要:4- (2,3- dichlorophenyl) -1,4- dihydro- 2,6- dimethyl- 5- methoxycarbonyl- 3- pyridinecarboxylic acid, a key intermediate in the synthesis of the cardiovascular calcium channel blocker drug 3-butanoyloxymethoxycarbonyl-5- methoxycarbonyl-4- (2,3-dichlorophenyl) -2,6- dimethyl-1,4- dihydropyridine, of purity greater than 97% and essentially free of the corresponding diacid, is prepared by a process involving selective precipitation of its carboxylate via addition of concentrated solutions of alkali metal salts. Similar intermediate mono-carboxylic acids useful in the synthesis of other unsymmetrically substituted dihydropyrine drugs such as nisoldipine, nitrendipine and nimodipine can be similarly prepared and purified.

    专利号:US-8455655-B2
    优先权日:2010-05-07
    标题:Preparation of dihydropyridines
    发明人:VISHNU NEWADKAR RAVINDRANATH; PURUSHOTTAM JOSHI ANIL; KUMAR SINGH SANTOSH
    权利人:VISHNU NEWADKAR RAVINDRANATH; PURUSHOTTAM JOSHI ANIL; KUMAR SINGH SANTOSH; LESVI LABORATORIOS SL
    摘要:The invention relates to a method and compounds for the preparation of clevidipine butyrate, a very short acting hypertensive calcium antagonist, as well as the synthesis of these compounds useful for the preparation of clevidipine (also known as clevidipine butyrate). Moreover the invention also discloses polymorphic forms of clevidipine butyrate, useful for the preparation of pharmaceutical compositions, and processes to prepare them.

    专利号:CA-2701272-A1
    优先权日:2010-04-21
    标 题 :Preparation of intermediates for the synthesis of dihydropyridine calcium channel blockers

    专利号:US-5258519-A
    优先权日:1990-11-13
    标 题:Dihydropyridine vasodilators agents
    发明人:WHEELER THOMAS N; KENAKIN TERRENCE P
    权利人:GLAXO INC
    摘要:Compounds of the following formula (I): (I) where R1 and R2 are alkyl or cycloalkyl, which may be substituted, R4 is aryl such as phenyl which may be substituted, L is a direct bond or an oxygen containing linking group, R is a hydrogen, alkyloxy, alkyl, halogen or haloalkyl and Het is a pyridinyl or pyridazinyl group. The compounds can be used antihypertensives or myocardial relaxants. Also part of the invention are pharmaceutical compositions, intermediates and methods of synthesis.

    专利号:US-5100892-A
    优先权日:1990-11-13
    标 题 :Dihydropyridine vasodilator agents
    发明人:WHEELER THOMAS N; KENAKIN TERRENCE P
    权利人:GLAXO INC
    摘要:Compounds of the following formula (I): (I) where R1 and R2 are alkyl or cycloalkyl, which may be substituted, R4 is aryl such as phenyl which may be substituted, L is a direct bond or an oxygen containing linking group, R is a hydrogen, alkyloxy, alkyl, halogen or haloalkyl and Het is a pyridinyl or pyridazinyl group. The compounds can be used antihypertensives or myocardial relaxants. Also part of the invention are pharmaceutical compositions, intermediates and methods of synthesis.
    安润医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    联系方式: (0512) 6295-4815👤
    ⚠️参考联系方式
    (0512) 6295-4815
    传真:(0512) 6296-4760
    邮件:sales@arromax.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    传真:(0512) 6296-4760
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献

    参考DOI号:10.1016/S0040-4039(00)93560-3
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知